Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Washington, DC
SEC filing record 1 source field available
Fiscal year end
31 December
60 DEGREES PHARMACEUTICALS, INC. has filed 217 SEC EDGAR filings since 18 Oct 2022

SEC filing history

Showing 76-100 of 217 matching filings.

Per page
25
Current page
4
D File 021-537991

D filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-537989

D filing

Filing date
11 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94258

SCHEDULE 13G filing

Filing date
11 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
06 Feb 2025
Reporting date
05 Feb 2025
Next action
Verify source filing
424B5 File 333-280796

PROSPECTUS SUPPLEMENT

Filing date
06 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94258

SCHEDULE 13G filing

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
30 Jan 2025
Reporting date
28 Jan 2025
Next action
Verify source filing
424B5 File 333-280796

PROSPECTUS SUPPLEMENT

Filing date
30 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
28 Jan 2025
Reporting date
28 Jan 2025
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jan 2025
Reporting date
17 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jan 2025
Reporting date
17 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
08 Jan 2025
Reporting date
08 Jan 2025
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Dec 2024
Reporting date
12 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Dec 2024
Reporting date
05 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Nov 2024
Reporting date
19 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94258

SC 13G filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41719

QUARTERLY REPORT

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
SC 13G/A File 005-94258

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
06 Nov 2024
Reporting date
06 Nov 2024
Next action
Verify source filing
DEF 14A File 001-41719

PROXY STATEMENT

Filing date
15 Oct 2024
Reporting date
06 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
08 Oct 2024
Reporting date
02 Oct 2024
Next action
Verify source filing
PRE 14A File 001-41719

PROXY STATEMENT

Filing date
02 Oct 2024
Reporting date
02 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-282221

EFFECT filing

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .